Amitriptyline for Feet Paresthesias
Amitriptyline is not recommended as a first-line treatment for feet paresthesias, with pregabalin or duloxetine being preferred options based on current guidelines. 1
Treatment Algorithm for Feet Paresthesias
First-Line Options (Evidence-Based)
- Pregabalin (starting at 75mg twice daily, up to 300mg twice daily)
- Duloxetine (60-120mg daily)
These medications have received FDA approval specifically for neuropathic pain and have stronger evidence supporting their efficacy 1.
Second-Line Options
- Gabapentin (starting at 300mg at bedtime, up to 2400mg daily divided into 3 doses)
- Venlafaxine (up to 75mg daily)
Third-Line Options (Including Amitriptyline)
- Amitriptyline (10-75mg at bedtime)
- Sodium channel blockers (mexiletine, carbamazepine)
- Topical treatments (lidocaine 5% patches, capsaicin)
Amitriptyline's Role in Treating Paresthesias
Amitriptyline is a tricyclic antidepressant that works by:
- Inhibiting serotonin and norepinephrine reuptake
- Blocking sodium channels required for neuronal impulses 1
While amitriptyline has been used for neuropathic pain for decades, current guidelines place it as a third-line option due to:
- Limited high-quality evidence supporting its efficacy
- Significant side effect profile, particularly in older adults
- Availability of better-tolerated alternatives with stronger evidence
According to the 2023 Mayo Clinic guideline, amitriptyline is considered only after trials of first and second-line agents for neuropathic pain conditions 1.
Important Considerations When Using Amitriptyline
If choosing amitriptyline despite its third-line status:
- Start low: Begin with 10-25mg at bedtime and titrate slowly
- Monitor for side effects: Anticholinergic effects (dry mouth, sedation, constipation) are common even at low doses 2
- Use caution in elderly patients: Risk of orthostatic hypotension, falls, and cognitive effects 2
- Consider topical application: In some cases, topical amitriptyline (1-2% compounded with 0.5% ketamine) may provide localized relief with fewer systemic effects 1, though systematic reviews question its efficacy 3
Potential Pitfalls and Caveats
- Risk of adverse effects: Anticholinergic side effects can limit tolerability, especially in older adults 1
- Paradoxical effect: Rarely, amitriptyline itself can cause peripheral neuropathy with prolonged use or overdose 4
- Limited efficacy: Even in positive studies, only about 38% of patients achieve adequate pain relief with amitriptyline versus 16% with placebo 5
- Drug interactions: Amitriptyline has numerous potential drug interactions that must be considered
Alternative Approaches
For patients who cannot tolerate oral medications or have inadequate response:
- Topical lidocaine patches (5%) applied to painful areas for up to 12 hours daily 1
- Capsaicin (0.025-0.075% cream or 8% patch) for localized neuropathic pain 1
- Referral to pain specialist for refractory cases 1
In conclusion, while amitriptyline has historically been used for neuropathic pain including feet paresthesias, current evidence and guidelines favor pregabalin or duloxetine as first-line treatments with better efficacy and safety profiles.